Kerényi Adrienne

1.

Kerényi, A., Schlammadinger, Á., Szegedi, I., Kiss, C., Marton, I., Bagoly, Z., Gindele, R., Boda, Z., Kappelmayer, J., Bereczky, Z.: von Willebrand betegség komplex laboratóriumi diagnosztikája egyetemi központban.
Hematol. Trasnzfuziol. 57 (3), 182, 2024.

DEA

2.

Kovács, E., Bereczky, Z., Kerényi, A., Laczik, R., Nagy, V., Kovács, D. Á., Kovács, S., Pfliegler, G.: Clinical investigation of hereditary and acquired thrombophilic factors in patients with venous and arterial thromboembolism.
Int J Gen Med. 16, 5425-5437, 2023.

doi DEA WoS

3.

Bereczki, D., Nagy, B. J., Kerényi, A., Nagy, G., Szarka, K., Kristóf, K., Szalay, B., Vásárhelyi, B., Bhattoa, H. P., Kappelmayer, J.: EDTA-Induced Pseudothrombocytopenia Up to 9 Months After Initial COVID-19 Infection Associated with Persistent Anti-SARS-CoV-2 IgM/IgG Seropositivity.
Lab. Med. 53 (2), 206-209, 2022.

doi DEA WoS Scopus

Journal metrics:

Q3 Biochemistry (medical)

Q3 Clinical Biochemistry

4.

Szabó, G., Antal-Szalmás, P., Kerényi, A., Pénzes-Daku, K., Bécsi, B., Kappelmayer, J.: Laboratory Approaches to Test the Function of Antiphospholipid Antibodies.
Semin. Thromb. Hemost. 48 (2), 132-144, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

Q1 Hematology

5.

Gindele, R., Kerényi, A., Kállai, J., Pfliegler, G., Schlammadinger, Á., Szegedi, I., Major, T., Szabó, Z., Bagoly, Z., Kiss, C., Kappelmayer, J., Bereczky, Z.: Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing.
Life (Basel). 11 (3), 1-23, (article identifier: 202), 2021.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Ecology, Evolution, Behavior and Systematics

Q2 Paleontology

Q3 Space and Planetary Science

6.

Mezei, G., Bekéné Debreceni, I., Kerényi, A., Reményi, G., Szász, R., Illés, Á., Kappelmayer, J., Batár, P.: Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia.
Platelets. 30 (7), 836-843, 2019.

doi DEA

Journal metrics:

Q2 Hematology

Q1 Medicine (miscellaneous)

7.

Muszbek, L., Pénzes-Daku, K., Katona, É., Kun, M., Bonnefoy, A., Vezina, Z., Szuber, N., Molnárné Rázsó, K., Bereczky, Z., Kerényi, A., Bécsi, B., Erdődi, F., Rivard, G. E.: Novel approach to the laboratory diagnosis of antibodies against coagulation factors, with special reference to antifactor XIII antibodies: SE2.4.
Clin. Chem. Lab. Med. 56 (9), 128-129, 2018.

DEA

8.

Muszbek, L., Katona, É., Kerényi, A.: Assessment of Factor XIII.
In: Hemostasis and Thrombosis. Eds.: Emmanuel J. Favaloro, Giuseppe Lippi, Humana Press Inc., New York, 277-297, 2017. ISBN: 9781493971947

doi DEA

9.

Kerényi, A., Bekéné Debreceni, I., Oláh, Z., Ilonczai, P., Bereczky, Z., Nagy, B. J., Muszbek, L., Kappelmayer, J.: Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome.
Cytom. Part B-Clin. Cytom. 92 (5), 389-397, 2017.

doi DEA

Journal metrics:

Q3 Cell Biology

Q2 Histology

Q1 Pathology and Forensic Medicine

10.

Berkes, A., Szikszay, E., Kappelmayer, J., Kerényi, A., Szabó, T., Újhelyi, L., Bari, K., Balla, G., Balla, J.: Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome.
Case Reports in Critical Care. 2017, 1-5, 2017.

doi DEA

11.

Póka, R., Damjanovich, P. G., Károlyi, P. K., Miszti-Blasius, K., Kerényi, A., Kappelmayer, J.: A firinogénszint referenciaértékei várandósságban.
Magy. Nőorv. Lapok. 79, 10-19, 2016.

DEA

12.

Bereczky, Z., Speker, M., Gindele, R., Szabó, Z., Oláh, Z., Pfliegler, G., Kerényi, A., Boda, Z.: Diagnostic issues in antithrombin, protein C and protein S deficiency in the hungarian population: experience of a large thrombosis laboratory.
J. Throm. Haemost. 14 (Suppl.), 98, 2016.

doi DEA WoS

13.

Póka, R., Damjanovich, P. G., Károlyi, P. K., Miszti-Blasius, K., Kerényi, A., Kappelmayer, J.: Fibrinogen levels in pregnancy have a prognostic role in preeclampsia and in massive obstetric haemorrhage.
Eur. J. Obstet. Gynecol. Reprod. Biol. 206, 259, 2016.

DEA

14.

Póka, R., Damjanovich, P. G., Károlyi, P. K., Miszti-Blasius, K., Kerényi, A., Kappelmayer, J.: Fibrinogen levels in pregnancy have a prognostic role in preeclampsia and in massive obstetric haemorrhage.
Eur. J. Obstet. Gynecol. Reprod. Biol. 206, P259, 2016.

doi DEA

15.

Szűk, T., Fejes, Z., Bekéné Debreceni, I., Kerényi, A., Édes, I. F., Kappelmayer, J., Nagy, B. J.: Integrity bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience everolimus-eluting stents in stable angina patients.
Platelets. 27 (5), 410-419, 2016.

doi DEA

Journal metrics:

Q2 Hematology

Q2 Medicine (miscellaneous)

16.

Pénzes-Daku, K., Molnárné Rázsó, K., Katona, É., Kerényi, A., Kun, M., Muszbek, L.: Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome: characterization of the antibody.
J. Thromb. Haemost. 14 (8), 1517-1520, 2016.

doi DEA WoS Scopus

Journal metrics:

D1 Hematology

D1 Medicine (miscellaneous)

17.

Ilonczai, P., Oláh, Z., Selmeczi, A., Kerényi, A., Bereczky, Z., Póka, R., Schlammadinger, Á., Boda, Z.: Management and outcome of pregnancies in women with antithrombin deficiency: a single-center experience and review of literature.
Blood Coagul. Fibrinolysis. 26 (7), 798-804, 2015.

DEA

Journal metrics:

Q3 Hematology

Q2 Medicine (miscellaneous)

18.

Árokszállási, A., Kerényi, A., Katona, É., Bereczky, Z., Muszbek, L., Boda, Z., Schlammadinger, Á.: The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency - the first experience.
Haemophilia. 21 (1), e118-e121, 2015.

doi DEA

Journal metrics:

Q3 Genetics (clinical)

Q2 Hematology

Q1 Medicine (miscellaneous)

19.

Tóth, J., Lenkey, Á., Oláh, A., Köteles, J., Kissné, S. V., Kerényi, A., Kappelmayer, J.: Pneumatic tube system for transport of laboratory samples: preanalytical aspects.
Orvosi Hetilap. 155 (28), 1113-1120, 2014.

doi DEA

Journal metrics:

Q3 Medicine (miscellaneous)

20.

Kovács, B., Bereczky, Z., Selmeczi, A., Gindele, R., Oláh, Z., Kerényi, A., Boda, Z., Muszbek, L.: Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.
Clin. Chem. Lab. Med. 52 (12), 1797-1806, 2014.

doi DEA

Journal metrics:

Q2 Biochemistry (medical)

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

21.

Oláh, Z., Szarvas, M., Bereczky, Z., Kerényi, A., Kappelmayer, J., Boda, Z.: Direct thrombin inhibitors and factor Xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.
Arch. Pathol. Lab. Med. 137 (7), 967-973, 2013.

DEA

Journal metrics:

D1 Medical Laboratory Technology

Q1 Medicine (miscellaneous)

Q1 Pathology and Forensic Medicine

22.

Bárdi, E., Jáger, R., Kerényi, A., Schmalcl, E., Schneider, F., Szegedi, I., Kiss, C.: Laboreltérés vagy betegség: APTI idő megnyúlásának hátterében áIIó két eltérés egy beteg esetében.
Hematol. Transzfuziol. 46 (2), 138-140, 2013.

DEA

23.

Kovács, B., Bereczky, Z., Oláh, Z., Gindele, R., Kerényi, A., Selmeczi, A., Boda, Z., Muszbek, L.: The Superiority of Anti-FXa Assay Over Anti-FIIa Assay in Detecting Heparin-Binding Site Antithrombin Deficiency.
Am. J. Clin. Pathol. 140 (5), 675-679, 2013.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Pathology and Forensic Medicine

24.

Benyó, M., Flaskó, T., Molnár, Z., Kerényi, A., Batta, Z., Józsa, T., Hársfalvi, J.: Follow-Up of Thrombin Generation after Prostate Cancer Surgery: Global Test for Increased Hypercoagulability.
PLoS One. 7 (12), e51299, 2012.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

25.

Nagy, B. J., Miszti-Blasius, K., Kerényi, A., Clemetson, K. J., Kappelmayer, J.: Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.
Curr. Med. Chem. 19 (4), 518-531, 2012.

doi DEA

Journal metrics:

Q2 Molecular Medicine

Q1 Pharmacology

Kerényi Adrienne

Publication list